机译:抗EGFR抗体西妥昔单抗由口腔鳞状细胞癌分泌,改变EGF驱动的间充质转换
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Department of Oral Diagnosis and Dent-maxillofacial Radiology Graduate School of Medicine;
Advanced Research Center for Oral and Craniofacial Sciences Graduate School of Medicine Dentistry;
Department of Oral Diagnosis and Dent-maxillofacial Radiology Graduate School of Medicine;
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Department of Radiation Oncology Beth Israel Deaconess Medical Center Harvard Medical School;
Department of Dental Pharmacology Graduate School of Medicine Dentistry and Pharmaceutical;
Extracellular vesicles; Anti-EGFR antibody therapy; Cetuximab; Epithelial-to-mesenchymal transition; Head and neck squamous cell carcinoma;
机译:抗EGFR抗体西妥昔单抗由口腔鳞状细胞癌分泌,改变EGF驱动的间充质转换
机译:由口服癌外泌体引发的致癌性上皮 - 间充质转变被抗EGFR抗体抗体抑制
机译:抗EGFR抗体西妥昔单抗可部分抑制辐射诱导的HIF-1α上调,从而使人的头颈部鳞状细胞癌细胞对辐射敏感
机译:PLK1通过诱导上皮 - 间充质转换来促进食管鳞状细胞癌细胞的侵袭
机译:人口腔鳞状细胞癌细胞中基因表达的改变调控。
机译:埃里布林通过诱导间充质向上皮转化使口腔鳞状细胞癌细胞对西妥昔单抗敏感
机译:抗EGFR抗体西汀昔单抗由口腔鳞状细胞癌分泌,改变EGF驱动的间充质转换